Data Science as Machinic Neoplatonism

Data science is not simply a method but an organising idea. Commitment to the new paradigm overrides concerns caused by collateral damage, and only a counterculture can constitute an effective critique. Understanding data science requires an appreciation of what algorithms actually do; in particular, how machine learning learns. The resulting ‘insight through opacity’ drives the observable problems of algorithmic discrimination and the evasion of due process. But attempts to stem the tide have not grasped the nature of data science as both metaphysical and machinic. Data science strongly echoes the neoplatonism that informed the early science of Copernicus and Galileo. It appears to reveal a hidden mathematical order in the world that is superior to our direct experience. The new symmetry of these orderings is more compelling than the actual results. Data science does not only make possible a new way of knowing but acts directly on it; by converting predictions to pre-emptions, it becomes a machinic metaphysics. The people enrolled in this apparatus risk an abstraction of accountability and the production of ‘thoughtlessness’. Susceptibility to data science can be contested through critiques of science, especially standpoint theory, which opposes the ‘view from nowhere’ without abandoning the empirical methods. But a counterculture of data science must be material as well as discursive. Karen Barad’s idea of agential realism can reconfigure data science to produce both non-dualistic philosophy and participatory agency. An example of relevant praxis points to the real possibility of ‘machine learning for the people’

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Optical band gap of NpO2 and PuO2 from optical absorbance of epitaxial films

We report a solution based synthesis of epitaxial thin films of neptunium oxide and plutonium oxide. Actinides represent a challenge to first principle calculations due to features that arise from f orbital interactions. Conventional semi-local density functional theory predicts NpO2 and PuO2 to be metallic, when they are well known insulators. Improvements in theory are dependent on comparison with accurate measurements of material properties, which in turn demand high-quality samples. The high melting point of actinide oxides and their inherent radioactivity makes single crystal and epitaxial film formation challenging. We report on the preparation of high quality epitaxial actinide films. The films have been characterized through a combination of X-ray diffraction and X-ray absorption fine structure (XANES and EXAFS) measurements. We report band gaps of 2.80 ± 0.1 eV and 2.85 ± 0.1 eV at room temperature for PuO2 and NpO2, respectively, and compare our measurements with state-of-the-art calculations